InsidersTradesSigma
Follow the Disc Medicine, Inc. stock price and the full insider trade history of the company, a publicly traded company based in United States. Shares trade on the US market, under the oversight of SEC (Form 4). Market capitalisation: €3.1bn. The latest transaction was reported on 4 September 2026 (Notice of proposed sale (Form 144)). Among the most active insiders: Quisel John D. All data is accessible without an account.
201
Insider Decl.
n/a
Thresholds
€21m
6 ops.
Buy Volume
€187m
99 ops.
Sell Volume
Analyst consensus: bullish or bearish?
Analysts rate Disc Medicine, Inc. Strong Buy (bullish), based on 12 analysts. Average price target: US$101.58.
43Σ signal
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Last declaration on 4 September 2026
Declarations201 total
2,212 shares@ US$79.37Common StockSEC144:0001628280-26-060745
18 shares@ US$79.37Common StockSEC144:0001628280-26-060748
912 shares@ US$79.37Common StockSEC144:0001628280-26-060746
759 shares@ US$79.37Common StockSEC144:0001628280-26-060747
70 shares@ US$79.950.0002% mcap0.0% of flowCommon StockSEC:0001591747-26-000002:0
58 shares@ US$79.950.0002% mcap0.0% of flowCommon StockSEC:0001591747-26-000002:1
1 shares@ US$79.950.0000% mcap0.0% of flowCommon StockSEC:0001591747-26-000002:2
26,542 shares@ US$80.170.070% mcap6.0% of flowCommon StockSEC:0001591747-26-000002:3
22,090 shares@ US$80.170.058% mcap5.0% of flowCommon StockSEC:0001591747-26-000002:4
511 shares@ US$80.170.0013% mcap0.1% of flowCommon StockSEC:0001591747-26-000002:5
10 shares@ US$80.980.0000% mcap0.0% of flowCommon StockSEC:0001591747-26-000002:6
9 shares@ US$80.980.0000% mcap0.0% of flowCommon StockSEC:0001591747-26-000002:7
2 shares@ US$80.980.0000% mcap0.0% of flowCommon StockSEC:0001591747-26-000002:8
2,810 shares@ US$79.980.0073% mcap0.6% of flowCommon StockSEC:0001591747-26-000002:9
2,339 shares@ US$79.980.0061% mcap0.5% of flowCommon StockSEC:0001591747-26-000002:10
54 shares@ US$79.980.0001% mcap0.0% of flowCommon StockSEC:0001591747-26-000002:11
6,822 shares@ US$80.05Common StockSEC144:0001628280-26-060502
54 shares@ US$80.05Common StockSEC144:0001628280-26-060507
2,810 shares@ US$80.05Common StockSEC144:0001628280-26-060504
2,339 shares@ US$80.05Common StockSEC144:0001628280-26-060505
300 shares@ US$13.500.0001% mcap0.3% of flowCommon StockSEC:0001193125-26-369179:0
300 shares@ US$82.53330.0008% mcap1.8% of flowCommon StockSEC:0001193125-26-369179:1
8,796 shares@ US$13.500.0038% mcap8.8% of flowCommon StockSEC:0001193125-26-369179:2
8,796 shares@ US$83.11640.024% mcap54.4% of flowCommon StockSEC:0001193125-26-369179:3
33,000 shares@ US$13.500.015% mcap5.3% of flowCommon StockSEC:0001193125-26-355841:0
25 of 201 declarations
Acerca de Disc Medicine, Inc.
Disc Medicine, Inc. es una empresa biofarmacéutica centrada en el desarrollo de tratamientos innovadores para trastornos sanguíneos. Cotiza en NASDAQ bajo el símbolo IRON.